Novel thiazolidinedione derivatives with anti-obesity effects: Dual action as PTP1B inhibitors and PPAR-γ activators

被引:98
作者
Bhattarai, Bharat Raj [2 ]
Kafle, Bhooshan [2 ]
Hwang, Ji-Sun [1 ]
Ham, Seung Wook [3 ]
Lee, Keun-Hyeung [2 ]
Park, Hwangseo [4 ]
Han, Inn-Oc [1 ]
Cho, Hyeongjin [2 ]
机构
[1] Inha Univ, Dept Physiol & Biophys, Coll Med, Inchon 402751, South Korea
[2] Inha Univ, Dept Chem, Inchon 402751, South Korea
[3] Chung Ang Univ, Dept Chem, Seoul 156756, South Korea
[4] Sejong Univ, Dept Biosci & Biotechnol, Seoul 143747, South Korea
关键词
Protein tyrosine phosphatase; Thiazolidinedione; PTP1B inhibitor; PPAR-gamma activator; Anti-obesity; TYROSINE-PHOSPHATASE; 1B; INSULIN SENSITIVITY; RESISTANCE; DISCOVERY; OBESITY; 5-ARYLIDENE-2,4-THIAZOLIDINEDIONES; ADD-3878; DOMAINS; DESIGN; MICE;
D O I
10.1016/j.bmcl.2010.08.130
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Benzylidene-2,4-thiazolidinedione derivatives with substitutions at both the ortho and para-positions of the phenyl group were synthesized as PTP1B inhibitors with IC50 values in a low micromolar range. Compound 18l, the lowest, bore an IC50 of 1.3 mu M. In a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) promoter reporter gene assay, 18l was found to activate the transcription of the reporter gene with potencies comparable to those of troglitazone, rosiglitazone, and pioglitazone. In vivo efficacy of 18l as an anti-obesity and hypoglycemic agent was evaluated in a mouse model system. Compound 18l significantly suppressed weight gain and significantly improved blood parameters such as TG, total cholesterol and NEFA without overt toxic effects. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6758 / 6763
页数:6
相关论文
共 30 条
[1]
OSMOTIC LOADING OF NEUTRALIZING ANTIBODIES DEMONSTRATES A ROLE FOR PROTEIN-TYROSINE-PHOSPHATASE 1B IN NEGATIVE REGULATION OF THE INSULIN ACTION PATHWAY [J].
AHMAD, F ;
LI, PM ;
MEYEROVITCH, J ;
GOLDSTEIN, BJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (35) :20503-20508
[2]
Structural and evolutionary relationships among protein tyrosine phosphatase domains [J].
Andersen, JN ;
Mortensen, OH ;
Peters, GH ;
Drake, PG ;
Iversen, LF ;
Olsen, OH ;
Jansen, PG ;
Andersen, HS ;
Tonks, NK ;
Moller, NPH .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (21) :7117-7136
[3]
Bailey CJ, 2000, DIABETIC MED, V17, P414
[4]
Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects [J].
Bhattarai, Bharat Raj ;
Kafle, Bhooshan ;
Hwang, Ji-Sun ;
Khadka, Deegendra ;
Lee, Sun-Myung ;
Kang, Jae-Seung ;
Ham, Seung Wook ;
Han, Inn-Oc ;
Park, Hwangseo ;
Cho, Hyeongjin .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (21) :6161-6165
[5]
Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B [J].
Cheng, A ;
Uetani, N ;
Simoncic, PD ;
Chaubey, VP ;
Lee-Loy, A ;
McGlade, CJ ;
Kennedy, BP ;
Tremblay, ML .
DEVELOPMENTAL CELL, 2002, 2 (04) :497-503
[6]
Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics [J].
Combs, AP ;
Yue, EW ;
Bower, M ;
Ala, PJ ;
Wayland, B ;
Douty, B ;
Takvorian, A ;
Polam, P ;
Wasserman, Z ;
Zhu, WY ;
Crawley, ML ;
Pruitt, J ;
Sparks, R ;
Glass, B ;
Modi, D ;
McLaughlin, E ;
Bostrom, L ;
Li, M ;
Galya, L ;
Blom, K ;
Hillman, M ;
Gonneville, L ;
Reid, BG ;
Wei, M ;
Becker-Pasha, M ;
Klabe, R ;
Huber, R ;
Li, YL ;
Hollis, G ;
Burn, TC ;
Wynn, R ;
Liu, P ;
Metcalf, B .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (21) :6544-6548
[7]
Thiazolidinediones: a new class of antidiabetic drugs [J].
Day, C .
DIABETIC MEDICINE, 1999, 16 (03) :179-192
[8]
Thiazolidinediones in type 2 diabetes mellitus - Current clinical evidence [J].
Diamant, M ;
Heine, RJ .
DRUGS, 2003, 63 (13) :1373-1405
[9]
Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene [J].
Elchebly, M ;
Payette, P ;
Michaliszyn, E ;
Cromlish, W ;
Collins, S ;
Loy, AL ;
Normandin, D ;
Cheng, A ;
Himms-Hagen, J ;
Chan, CC ;
Ramachandran, C ;
Gresser, MJ ;
Tremblay, ML ;
Kennedy, BP .
SCIENCE, 1999, 283 (5407) :1544-1548
[10]
REDUCTION OF INSULIN RESISTANCE IN OBESE AND OR DIABETIC ANIMALS BY 5-[4-(1-METHYLCYCLOHEXYLMETHOXY)BENZYL]-THIAZOLIDINE-2,4-DIONE (ADD-3878, U-63,287, CIGLITAZONE), A NEW ANTI-DIABETIC AGENT [J].
FUJITA, T ;
SUGIYAMA, Y ;
TAKETOMI, S ;
SOHDA, T ;
KAWAMATSU, Y ;
IWATSUKA, H ;
SUZUOKI, Z .
DIABETES, 1983, 32 (09) :804-810